A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Who could take the new weight-loss pill? In a nine-month trial on patients with type 2 diabetes, those on the highe ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

Tirzepatide is approved for 3 indications in the US: type 2 diabetes, chronic weight management, and obstructive sleep apnea.

Novo Nordisk will pay as much as $2 billion for a new obesity drug called ... expand its lineup of advanced weight-loss treatments. Although the company’s drugs have been popular, trials ...

A decision by CMS to not move forward with a proposed rule allowing obesity medications to be covered under Medicare Part D ...